Association study of MAO-A, COMT, 5-HT2A, DRD2, and DRD4 Polymorphisms with illness time course in mood disorders

被引:48
作者
Cusin, C [1 ]
Serretti, A [1 ]
Lattuada, E [1 ]
Lilli, R [1 ]
Lorenzi, C [1 ]
Smeraldi, E [1 ]
机构
[1] Univ Vita Salute San Raffaele, Ist Sci H San Raffaele, Dept Psychiat, Fdn Ctr San Raffaele Monte Tabor, I-20127 Milan, Italy
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 2002年 / 114卷 / 04期
关键词
bipolar disorder; longitudinal studies; depressive disorder; rapid cycling; genetics;
D O I
10.1002/ajmg.10358
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The aim of our study was to investigate a possible influence of monoamine oxydase A (MAO-A), catechol-O-methyltransferase (COMT), serotonin receptor 2A (5-HT2A), dopamine receptor D2 (DRD2), and dopamine receptor D4 (DRD4) gene variants on timing of recurrence in mood disorders. Gene variants were determined using PCR-based techniques in 550 inpatients affected by recurrent mood disorders (major depressives: n = 212; bipolars: n = 338), rapid cycling mood disorder (n 8 1), and 663 controls. We investigated possible genetic influences by comparing illness time course of subjects subdivided according to genotype using multivariate analysis of variance (MAN-OVA). We could not observe a significantly different time course. No demographic and clinical variables such as sex, age or polarity of onset, presence of psychotic features, genetic loading, or education level influenced the observed results. Our results suggest that MAO-A, COMT, 5-HT2A, DRD2, and DRD4 gene variants are not involved in susceptibility toward different time courses in mood disorders. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:380 / 390
页数:11
相关论文
共 130 条
[1]   CATECHOL O-METHYLTRANSFERASE PHARMACOGENETICS - PHOTOAFFINITY-LABELING AND WESTERN-BLOT-ANALYSIS OF HUMAN LIVER SAMPLES [J].
AKSOY, S ;
KLENER, J ;
WEINSHILBOUM, RM .
PHARMACOGENETICS, 1993, 3 (02) :116-122
[2]  
ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229
[3]   The depressive spectrum: Diagnostic classification and course [J].
Angst, J ;
Merikangas, K .
JOURNAL OF AFFECTIVE DISORDERS, 1997, 45 (1-2) :31-39
[4]   THE COURSE OF AFFECTIVE-DISORDERS [J].
ANGST, J .
PSYCHOPATHOLOGY, 1986, 19 :47-52
[5]  
Angst J., 1981, HDB BIOL PSYCHIAT 5, P225
[6]  
[Anonymous], 1994, Am J Psychiatry, V151, P1
[7]   ASSOCIATION OF DOPAMINE D2 RECEPTOR MOLECULAR VARIANT WITH SCHIZOPHRENIA [J].
ARINAMI, T ;
ITOKAWA, M ;
ENGUCHI, H ;
TAGAYA, H ;
YANO, S ;
SHIMIZU, H ;
HAMAGUCHI, H ;
TORU, M .
LANCET, 1994, 343 (8899) :703-704
[8]   5-HT2A receptor and bipolar affective disorder: Association studies in affected patients [J].
Arranz, MJ ;
Erdmann, J ;
Kirov, G ;
Rietschel, M ;
Sodhi, M ;
Albus, M ;
Ball, D ;
Maier, W ;
Davies, N ;
Franzek, E ;
Abusaad, I ;
Weigelt, B ;
Murray, R ;
ShimronAbarbanell, D ;
Kerwin, R ;
Propping, P ;
Sham, P ;
Nothen, MM ;
Collier, DA .
NEUROSCIENCE LETTERS, 1997, 224 (02) :95-98
[9]   MODULATION OF INTRACELLULAR CYCLIC-AMP LEVELS BY DIFFERENT HUMAN DOPAMINE D4 RECEPTOR VARIANTS [J].
ASGHARI, V ;
SANYAL, S ;
BUCHWALDT, S ;
PATERSON, A ;
JOVANOVIC, V ;
VANTOL, HHM .
JOURNAL OF NEUROCHEMISTRY, 1995, 65 (03) :1157-1165
[10]   Response to clozapine in acute mania is more rapid than that of chlorpromazine [J].
Barbini, B ;
Scherillo, P ;
Benedetti, F ;
Crespi, G ;
Colombo, C ;
Smeraldi, E .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1997, 12 (02) :109-112